The University of Nottingham would like to invite you to take part in our research study which is being undertaken for educational purposes as part of a PhD. 

This study is aiming to explore the impact on quality of life caused by hearing loss and/or tinnitus from chemotherapy.  Some chemotherapy, such as cisplatin, sometime causes hearing problems and/or tinnitus and it may be permanent. There is little research done on this side effect and we want to find out how many people have it and how we can improve the support given. We want to find out what specific problems you face and how we can help solve them.

You are eligible to participate in this study if you: 

  • Have had chemotherapy in the past, in doesn't matter how long ago
  • Have experienced hearing loss and/or tinnitus
  • Were diagnosed with cancer as an adult (18+)
  • Are fluent in the English Language

The study involves performing a simple hearing test, completing three short questionnaires and doing a recorded interview lasting 30-60 minutes at a place and time of your convenience.

Taking part is voluntary and you can withdraw at any time. All personal data will be kept confidential and stored on University of Nottingham secure facilities.

There are no health risks in taking part in the research; however, some of the topics discussed in the interview, such as your experience of chemotherapy, can be difficult for some people. If this happens, support will be available to you.

The study aims to educate healthcare professionals to offer the right support for people who are suffering from hearing loss and tinnitus caused by chemotherapy. It will also help future research by giving them the information they need to improve management and support. 

If you would like to take part, please read the information sheet below:

Information_Sheet.pdf

If you have any more questions or want to know more, please contact Stephanie Pearson on [email protected] or on 0115 823 2611.